Form 4: Cencora CEO Robert Mauch Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Cencora's CEO, Robert P. Mauch, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 18, 2025, Robert P. Mauch, the President & CEO of Cencora, Inc., executed a transaction involving Cencora's common stock.
- Mauch exercised non-qualified stock options to acquire 3,226 shares at a price of $86.09 per share.
- Simultaneously, Mauch sold 3,226 shares at $260.93 and 1,744 shares at $260.93.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 15, 2024.
- Following these transactions, Mauch directly owns 49,326 shares of Cencora common stock and 38,702 derivative securities (non-qualified stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative performance for the company.
Industry Context
Executive stock transactions are common and closely monitored, especially in publicly traded companies like Cencora. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The use of Rule 10b5-1 trading plans is a standard practice among executives at publicly traded companies, including competitors like McKesson and Cardinal Health, to manage their stock holdings and avoid accusations of insider trading.
- The size and frequency of these transactions are typical for executives at this level, and the prices at which the shares were sold are within the normal range for market fluctuations.
Stakeholder Impact
- The stock sale could have a minor, temporary impact on the stock price, but the existence of a 10b5-1 plan suggests the sales are routine and planned.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/13/2020 | First exercisable date for a portion of the non-qualified stock options. |
| 11/13/2021 | Second exercisable date for a portion of the non-qualified stock options. |
| 11/13/2022 | Third exercisable date for a portion of the non-qualified stock options. |
| 11/13/2023 | Fourth exercisable date for a portion of the non-qualified stock options. |
| 11/15/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 03/18/2025 | Date of the stock option exercise and stock sales. |
| 03/19/2025 | Date of the Form 4 filing. |
| 11/13/2026 | Expiration date of the non-qualified stock options. |
Keywords
Cencora, Robert Mauch, Stock Options, Form 4, Insider Trading, Rule 10b5-1, Executive Compensation, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.